Norman Brenes-Cordero

Mr. Norman Brenes-Cordero

University of Costa Rica
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
IQIsaac Quiros-Fernandez
Isaac Quiros-Fernandez
Lucía Figueroa-ProttiLucía Figueroa-Protti
Lucía Figueroa-Protti
Jorge L. Arias-AriasJorge L. Arias-Arias
Jorge L. Arias-Arias
Norman Brenes-CorderoNorman Brenes-Cordero
Norman Brenes-Cordero
FCFrancisco Siles Canales
Francisco Siles Canales
RMRodrigo Mora
Rodrigo Mora
In the absence of new therapeutic strategies, chemotherapeutic drugs are the most widely used strategy against metastatic breast cancer, in spite of eliciting multiple adverse effects and having low responses with an average 5-year patient survival rate. Among the new therapeutic targets that are currently in clinical trials, here, we addressed the association between the regulation of the metabolic process of autophagy and the exposure of damage-associated molecular patterns associated (DAMPs) to immunogenic cell death (ICD), which has not been previously studied. After validating an mCHR-GFP tandem LC3 sensor capacity to report dynamic changes of the autophagic metabolic flux in response to external stimuli and demonstrating that both basal autophagy levels and response to diverse autophagy regulators fluctuate among different cell lines, we explored the interaction between autophagy modulators and chemotherapeutic agents in regards of cytotoxicity and ICD using three different breast cancer cell lines. Since these interactions are very complex and variable throughout different cell lines, we designed a perturbation-based model in which we propose specific modes of action of chemotherapeutic agents on the autophagic flux and the corresponding strategies of modulation to enhance the response to chemotherapy. Our results point towards a promising therapeutic potential of the metabolic regulation of autophagy to overcome chemotherapy resistance by eliciting ICD.